Succesful treatment of aggressive HIV-associated non-hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: Presentation of a therapeutic option

Leukemia and Lymphoma

Volumn 44, Issue 2, 2003, Pages 349-351

  Klepfish, A ^a   Schattner, A ^a   Shvidel, L ^a   Shtalrid, M ^a   Haran, M ^a   Bentwich, Z ^a   Berrebi, A ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

HIV; Lymphoma; Rituximab; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DIDANOSINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; NELFINAVIR; PREDNISONE; RITUXIMAB; STAVUDINE; MONOCLONAL ANTIBODY;

ADULT; AIDS RELATED COMPLEX; ANTIBIOTIC PROPHYLAXIS; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CASE REPORT; CELL COUNT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOLERABILITY; ETHIOPIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLASTIC LYMPHOMA; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VIRUS LOAD; OPPORTUNISTIC INFECTION; PATHOLOGY; REMISSION; VIROLOGY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, DIFFUSE; OPPORTUNISTIC INFECTIONS; REMISSION INDUCTION; VIRAL LOAD;

EID: 0141783978     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000060537     Document Type: Article

References (11)

1. DeMario, M.D. and Leibovitz, D.N. (1998) "Lymphomas in the immunocompromized patient", Semin. Oncol. 25, 492-502.
2. Levine, A.M., Seneviratne, L., Aspina, B.M., Wohl, A.R., Tilpule, A., Nathwani, B.N. and Gill, P.S. (2000) "Evolving characteristics of AIDS-related lymphoma", Blood 96, 4084-4090.
3. Grillo-Lopez, A.J. (2000) "Rituximab: an insider's historical perspective", Semin. Oncol. 27(Suppl. 12), 9-16.
4. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma", N. Engl. J. Med. 346(4), 235-242.
5. Milpied, N., Vasseur, B., Parquet, N., Gamier, J.L., Antoine, C., Quartier, A.S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A.M., Hurault de Ligny, B., Dubief, F., Mathieu-Boue, A. and Leblond, V. (2000) "Humanized anti-CD20 monoclonal antibody (Rituximab) in transplant B-lymphoproliferative disorder: a retrospective study on 32 patients", Ann. Oncol. 11, 113-116.
6. Treon, S.P., Agus, D.B., Link, B., Rodrigues, G., Molina, A., Lacy, M.Q., Emmanouilides, C., Richards, A.I., Clark, B., Lucas, M.S., Schlossman, R., Schenkein, D., Lin, B., Kimby, E., Anderson, K.C. and Byrd, J.C. (2001) "CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia", J. Immunother. 24, 272-279.
7. Shvidel, L., Klepfish, A. and Berrebi, A. (2001) "Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma", Am. J. Hematol. 67, 213-214.
8. Cohen, Y., Polliack, A., Zelig, O. and Goldfarb, A. (2001) "Monotherapy with Rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in a patient with indolent lympho-plasmacytic lymphoma", Leuk. Lymphoma 42, 1405-1408.
9. Wilson, W.H. (2000) "Chemotherapy sensitization by Rituximab: experimental and clinical evidence", Semin. Oncol. 27(Suppl. 12), 30-36.
10. Sweetenham, J., Hieke, K., Kerrigan, M., Howard, P., Smartt, P.F., McIntosh, G. and Townshend, S. (1999) "Cost-minimization analysis of CHOP, fludarabine and Rituximab in the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.", Br. J. Haematol. 106, 47-54.
11. Perez, C.L. and Rudoy, S. (2001) "Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient", Clin. Diagn. Lab. Immunol. 8, 993-996.